(Q45203594)

10 December 2017

title

Central noradrenergic function in man: vanillylmandelic acid in CSF (English)

1 reference

https://api.crossref.org/works/10.1016/0006-8993(75)90051-7

22 October 2023

3

Post RM

1 reference

10 December 2017

D. C. Jimerson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1182564

22 October 2023

E. K. Gordon

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1182564

22 October 2023

F. K. Goodwin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1182564

22 October 2023

language of work or name

English

0 references

publication date

1 December 1975

1 reference

10 December 2017

5 December 1975

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1182564

full work available at URL

22 October 2023

https://api.elsevier.com/content/article/PII:0006899375900517?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-8993(75)90051-7

https://api.elsevier.com/content/article/PII:0006899375900517?httpAccept=text/plain

22 October 2023

1 reference

https://api.crossref.org/works/10.1016/0006-8993(75)90051-7

22 October 2023

1 reference

10 December 2017

volume

99

1 reference

10 December 2017

issue

2

1 reference

10 December 2017

page(s)

434-439

1 reference

Drug-induced changes in the concentration of 5-OR indolyl compounds in cerebrospinal fluid and caudate nucleus

10 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0006-8993(75)90051-7

Catecholamine metabolism in the dog: comparison of intravenously and intraventricularly administered [14C]dopamine and [3H]norepinephrine

22 October 2023

3

1 reference

https://api.crossref.org/works/10.1016/0006-8993(75)90051-7

Diagnostic Criteria for Use in Psychiatric Research

22 October 2023

5

1 reference

https://api.crossref.org/works/10.1016/0006-8993(75)90051-7

Cerebrospinal fluid amine metabolites in affective illness: the probenecid technique.

22 October 2023

7

1 reference

https://api.crossref.org/works/10.1016/0006-8993(75)90051-7

Simultaneous assay by mass fragmentography of vanillyl mandelic acid, homovanillic acid, and 3-methoxy-4-hydroxy-phenethylene glycol in cerebrospinal fluid and urine

22 October 2023

9

1 reference

https://api.crossref.org/works/10.1016/0006-8993(75)90051-7

Effect of probenecid on free 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) and its sulphate in human cerebrospinal fluid.

22 October 2023

10

1 reference

https://api.crossref.org/works/10.1016/0006-8993(75)90051-7

The effect of probenecid on catecholamine metabolites in human cerebrospinal fluid analyzed by mass fragmentography

22 October 2023

11

1 reference

https://api.crossref.org/works/10.1016/0006-8993(75)90051-7

Origins of catecholamine metabolites in monkey cerebrospinal fluid

22 October 2023

12

1 reference

https://api.crossref.org/works/10.1016/0006-8993(75)90051-7

Metabolism of dopamine and noradrenaline in rabbit caudate nucleus in vitro.

22 October 2023

14

1 reference

https://api.crossref.org/works/10.1016/0006-8993(75)90051-7

MHPG Excretion by Patients with Affective Disorders

22 October 2023

15

1 reference

https://api.crossref.org/works/10.1016/0006-8993(75)90051-7

In vivo studies of the metabolism of norepinephrine in the central nervous system

22 October 2023

16

1 reference

https://api.crossref.org/works/10.1016/0006-8993(75)90051-7

Cerebral metabolites in cerebrospinal fluid as a biochemical approach to the brain

22 October 2023

18

1 reference

https://api.crossref.org/works/10.1016/0006-8993(75)90051-7

Cerebrospinal Fluid Amine Metabolites in Acute Schizophrenia

22 October 2023

19

1 reference

https://api.crossref.org/works/10.1016/0006-8993(75)90051-7

Amine Metabolites in Human Cerebrospinal Fluid: Effects of Cord Transection and Spinal Fluid Block

22 October 2023

21

1 reference

https://api.crossref.org/works/10.1016/0006-8993(75)90051-7

Central Norepinephrine Metabolism in Affective Illness: MHPG in the Cerebrospinal Fluid

22 October 2023

22

1 reference

https://api.crossref.org/works/10.1016/0006-8993(75)90051-7

Psychomotor Activity and Cerebrospinal Fluid Amine Metabolites in Affective Illness

22 October 2023

23

1 reference

https://api.crossref.org/works/10.1016/0006-8993(75)90051-7

Catecholamine neurotransmitters and synthetic enzymes in the spinal cord of the rat

22 October 2023

24

1 reference

https://api.crossref.org/works/10.1016/0006-8993(75)90051-7

Cerebrospinal fluid MHPG. An assessment of norepinephrine metabolism in affective disorders.

22 October 2023

27

1 reference

https://api.crossref.org/works/10.1016/0006-8993(75)90051-7

Mass fragmentographic determination of 4-hydroxy-3-methoxymndelic acid in human urine, cerebrospinal fluid, brain and serum using a deuterium-labelled internal standard

22 October 2023

28

1 reference

https://api.crossref.org/works/10.1016/0006-8993(75)90051-7

Derivatization and gas chromatographic determination of some biologically important acids in cerebrospinal fluid

22 October 2023

29

1 reference

https://api.crossref.org/works/10.1016/0006-8993(75)90051-7

Dopamine-β-Hydroxylase Deficits in the Brains of Schizophrenic Patients

22 October 2023

31

1 reference

https://api.crossref.org/works/10.1016/0006-8993(75)90051-7

22 October 2023

Identifiers

1 reference

10 December 2017

1 reference